Benefit of Glycoprotein IIb/IIIa Inhibition in Patients With Acute Coronary Syndromes and Troponin T–Positive Status

Differential Effects of Glycoprotein IIb/IIIa Antagonists on

R. F. Storey
R. G. Wilcox
S. Heptinstall

February 2015

The online version of this article, along with updated information and services, is located on th

Platelet Glycoprotein IIb/IIIa Inhibitors Basic and Clinical Aspects

Alan T. Nurden
Christel Poujol
Catherine Durrieu-jais
Paquita Nurden
Arterioscler Thromb Vasc Biol
Alan T. Nurden
Christel Poujol
Catherine Durrieu-jais
Paquita Nurden

December 2014

The online version of this article, along with updated information and services, is located on th

Platelet Glycoprotein IIb/IIIa Receptor Inhibition in Non-ST-Elevation Acute Coronary Syndromes: Early Benefit During Medical Treatment Only, With Additional Protection During Percutaneous Coronary Intervention

Akkerhuis, Martijn
Théroux, Pierre
Califf, Robert
Topol, Eric
Simoons, Maarten
Boersma, Eric

January 1999

BACKGROUND: Glycoprotein (GP) IIb/IIIa receptor blockers prevent life-threatening cardiac com...

Pronounced Benefit of Coronary Stenting and Adjunctive Platelet Glycoprotein IIb/IIIa Inhibition in Complex

Eric J. Topol
Khaled M. Ziada
Katherine E. Wolski
David J. Moliterno
Sorin J. Brener
Stephen G. Ellis
O A. Cura
Deepak L. Bhatt
A. Michael Lincoff
Samir R. Kapadia
Atherosclerotic Lesions

August 2015

The online version of this article, along with updated information and services, is located on th

Is There Still a Role for Glycoprotein IIb/IIIa Antagonists in Acute Coronary Syndromes?

Articles The
Journal Cardiol Res
Loredana Iannettaa
Paolo Emilio Puddua
Domenico Cuturelloa
Angela Saladinib
Mariano Pellicanoa
Michele Schiaritia

September 2016

This is an open-access article distributed under the terms of the Creative Commons Attribution Licen...

Are Stenting and Glycoprotein IIb/IIIa Blockade of Good Value in Primary Percutaneous Coronary Intervention?

Jason H. Cole
William S. Weintraub
Jason H. Cole
Md William
S. Weintraub

March 2015

The online version of this article, along with updated information and services, is located on th

Effect of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction

Adnan Kastrati
Albert Schömig
Franz-josef Neumann
Rudolf Blasini
Claus Schmitt
Eckhard Alt
Josef Dirschinger
Myocardial Infarction

February 2015

The online version of this article, along with updated information and services, is located on th

Results From the Platelet Glycoprotein IIb/IIIa in Unstable Angina:

Robert M. Califf
Eric J. Topol
Paul W. Armstrong
Robert A. Harrington
Marino Labinaz
Rakhi Kilaru
Karen Pieper
Steven P. Marso
Michael M. Kitt
Maarten L
Paul W. Armstrong
Md Robert
A. Harrington
Md For The Pursuit Investigators

January 2015

The online version of this article, along with updated information and services, is located on th

Glycoprotein IIb/IIIa receptors and primary stenting in acute myocardial infarction

G. Montalescot
R. Choussat
J. P. Collet

January 2015

The past 15 years have seen great progress in the treatment of acute myocardial infarction (MI), wit...

Inhibitor Therapy for Acute Myocardial Infarction

J. Ward Kennedy
Michael L. Stadius
J. Ward Kennedy
Md Michael
L. Stadius

January 2015

The online version of this article, along with updated information and services, is located on th

Glycoprotein IIb/IIIa Receptor Blockade Improves Outcomes in Diabetic Patients Presenting With Unstable

Frederic L. Sax
Pierre Théroux
Joe Alex
Chantal Phar
Eliav Barr
Steven Snapinn
Asma F
Angina/non–st-elevation Myocardial Infarction
Steven Snapinn
Phd Asma
F. Ghannam
Msn Frederic
L. Sax

February 2015

The online version of this article, along with updated information and services, is located on th

Cost-Effectiveness of Platelet Glycoprotein IIb/IIIa Inhibition With Eptifibatide in Patients With Non–ST-Elevation Acute Coronary Syndromes

Eric J. Topol
Anastasios A. Tsiatis
Hope Buell
Kenneth W. Mahaffey
Linda Davidson-ray
Daniel B. Mark
Robert A. Harrington
A. Michael Lincoff
Robert M. Califf
Charlotte L

February 2015

The online version of this article, along with updated information and services, is located on th

Antithrombotic Effect of Platelet Glycoprotein Ib–Blocking

Jan P. Roodt
Levente Novák
Jolan Harsfalvi
Hans Deckmyn
Harry F. Kotzé
Nancy Cauwenberghs
Muriel Meiring
Stephan Vauterin
Veronika Van Wyk
Seb Lamprecht
Arterioscler Thromb Vasc Biol
In Nonhuman Primates
Nancy Cauwenberghs
Muriel Meiring
Stephan Vauterin
Veronika Van Wyk
Seb Lamprecht
Jan P. Roodt
Jolan Harsfalvi
Hans Deckmyn
Harry F. Kotzé

August 2015

The online version of this article, along with updated information and services, is located on th

August 2016

In patients undergoing percutaneous coronary intervention (PCI) for the treatment of acute coronary ...

The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor

Michael Kitt
Maarten Simoons
Eric J. Topol
Robert M. Califf
Robert A. Harrington
Lisa G. Berdan
A. Michael Lincoff
Jaap Deckers
Rafael Diaz
Karl R. Karsch
Daniel Gretler
Matthew W. Mcclure
Scott D. Berkowitz
Rodney Sparapani
Robert Tuttle
Neal S. Kleiman
Robert A. Harrington
Md For The Pursuit Investigators

August 2015

The online version of this article, along with updated information and services, is located on th

Differential Effects of Glycoprotein IIb/IIIa Antagonists on

R. F. Storey
R. G. Wilcox
S. Heptinstall

February 2015

The online version of this article, along with updated information and services, is located on th

Platelet Glycoprotein IIb/IIIa Inhibitors Basic and Clinical Aspects

Alan T. Nurden
Christel Poujol
Catherine Durrieu-jais
Paquita Nurden
Arterioscler Thromb Vasc Biol
Alan T. Nurden
Christel Poujol
Catherine Durrieu-jais
Paquita Nurden

December 2014

The online version of this article, along with updated information and services, is located on th

Platelet Glycoprotein IIb/IIIa Receptor Inhibition in Non-ST-Elevation Acute Coronary Syndromes: Early Benefit During Medical Treatment Only, With Additional Protection During Percutaneous Coronary Intervention

Akkerhuis, Martijn
Théroux, Pierre
Califf, Robert
Topol, Eric
Simoons, Maarten
Boersma, Eric

January 1999

BACKGROUND: Glycoprotein (GP) IIb/IIIa receptor blockers prevent life-threatening cardiac com...

Pronounced Benefit of Coronary Stenting and Adjunctive Platelet Glycoprotein IIb/IIIa Inhibition in Complex

Eric J. Topol
Khaled M. Ziada
Katherine E. Wolski
David J. Moliterno
Sorin J. Brener
Stephen G. Ellis
O A. Cura
Deepak L. Bhatt
A. Michael Lincoff
Samir R. Kapadia
Atherosclerotic Lesions

August 2015

The online version of this article, along with updated information and services, is located on th

Is There Still a Role for Glycoprotein IIb/IIIa Antagonists in Acute Coronary Syndromes?

Articles The
Journal Cardiol Res
Loredana Iannettaa
Paolo Emilio Puddua
Domenico Cuturelloa
Angela Saladinib
Mariano Pellicanoa
Michele Schiaritia

September 2016

This is an open-access article distributed under the terms of the Creative Commons Attribution Licen...

Are Stenting and Glycoprotein IIb/IIIa Blockade of Good Value in Primary Percutaneous Coronary Intervention?

Jason H. Cole
William S. Weintraub
Jason H. Cole
Md William
S. Weintraub

March 2015

The online version of this article, along with updated information and services, is located on th

Effect of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction

Adnan Kastrati
Albert Schömig
Franz-josef Neumann
Rudolf Blasini
Claus Schmitt
Eckhard Alt
Josef Dirschinger
Myocardial Infarction

February 2015

The online version of this article, along with updated information and services, is located on th

Results From the Platelet Glycoprotein IIb/IIIa in Unstable Angina:

Robert M. Califf
Eric J. Topol
Paul W. Armstrong
Robert A. Harrington
Marino Labinaz
Rakhi Kilaru
Karen Pieper
Steven P. Marso
Michael M. Kitt
Maarten L
Paul W. Armstrong
Md Robert
A. Harrington
Md For The Pursuit Investigators

January 2015

The online version of this article, along with updated information and services, is located on th

Glycoprotein IIb/IIIa receptors and primary stenting in acute myocardial infarction

G. Montalescot
R. Choussat
J. P. Collet

January 2015

The past 15 years have seen great progress in the treatment of acute myocardial infarction (MI), wit...

Inhibitor Therapy for Acute Myocardial Infarction

J. Ward Kennedy
Michael L. Stadius
J. Ward Kennedy
Md Michael
L. Stadius

January 2015

The online version of this article, along with updated information and services, is located on th

Glycoprotein IIb/IIIa Receptor Blockade Improves Outcomes in Diabetic Patients Presenting With Unstable

Frederic L. Sax
Pierre Théroux
Joe Alex
Chantal Phar
Eliav Barr
Steven Snapinn
Asma F
Angina/non–st-elevation Myocardial Infarction
Steven Snapinn
Phd Asma
F. Ghannam
Msn Frederic
L. Sax

February 2015

The online version of this article, along with updated information and services, is located on th

Cost-Effectiveness of Platelet Glycoprotein IIb/IIIa Inhibition With Eptifibatide in Patients With Non–ST-Elevation Acute Coronary Syndromes

Eric J. Topol
Anastasios A. Tsiatis
Hope Buell
Kenneth W. Mahaffey
Linda Davidson-ray
Daniel B. Mark
Robert A. Harrington
A. Michael Lincoff
Robert M. Califf
Charlotte L

February 2015

The online version of this article, along with updated information and services, is located on th

Antithrombotic Effect of Platelet Glycoprotein Ib–Blocking

Jan P. Roodt
Levente Novák
Jolan Harsfalvi
Hans Deckmyn
Harry F. Kotzé
Nancy Cauwenberghs
Muriel Meiring
Stephan Vauterin
Veronika Van Wyk
Seb Lamprecht
Arterioscler Thromb Vasc Biol
In Nonhuman Primates
Nancy Cauwenberghs
Muriel Meiring
Stephan Vauterin
Veronika Van Wyk
Seb Lamprecht
Jan P. Roodt
Jolan Harsfalvi
Hans Deckmyn
Harry F. Kotzé

August 2015

The online version of this article, along with updated information and services, is located on th

August 2016

In patients undergoing percutaneous coronary intervention (PCI) for the treatment of acute coronary ...

The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor

Michael Kitt
Maarten Simoons
Eric J. Topol
Robert M. Califf
Robert A. Harrington
Lisa G. Berdan
A. Michael Lincoff
Jaap Deckers
Rafael Diaz
Karl R. Karsch
Daniel Gretler
Matthew W. Mcclure
Scott D. Berkowitz
Rodney Sparapani
Robert Tuttle
Neal S. Kleiman
Robert A. Harrington
Md For The Pursuit Investigators

August 2015

The online version of this article, along with updated information and services, is located on th

Differential Effects of Glycoprotein IIb/IIIa Antagonists on

R. F. Storey
R. G. Wilcox
S. Heptinstall

February 2015

The online version of this article, along with updated information and services, is located on th

Platelet Glycoprotein IIb/IIIa Inhibitors Basic and Clinical Aspects

Alan T. Nurden
Christel Poujol
Catherine Durrieu-jais
Paquita Nurden
Arterioscler Thromb Vasc Biol
Alan T. Nurden
Christel Poujol
Catherine Durrieu-jais
Paquita Nurden

December 2014

The online version of this article, along with updated information and services, is located on th

Platelet Glycoprotein IIb/IIIa Receptor Inhibition in Non-ST-Elevation Acute Coronary Syndromes: Early Benefit During Medical Treatment Only, With Additional Protection During Percutaneous Coronary Intervention

Akkerhuis, Martijn
Théroux, Pierre
Califf, Robert
Topol, Eric
Simoons, Maarten
Boersma, Eric

January 1999

BACKGROUND: Glycoprotein (GP) IIb/IIIa receptor blockers prevent life-threatening cardiac com...

Benefit of Glycoprotein IIb/IIIa Inhibition in Patients With Acute Coronary Syndromes and Troponin T–Positive Status

Abstract

Extracted data

Benefit of Glycoprotein IIb/IIIa Inhibition in Patients With Acute Coronary Syndromes and Troponin T–Positive Status

Abstract

Extracted data

Related items

Related items